Trial Profile
A SINGLE-CENTER, OPEN-LABEL, RANDOMIZED, TWO SEQUENCE, 3-WAY CROSSOVER STUDY TO INVESTIGATE THE INTERACTION BETWEEN MULTIPLE DOSES OF COLISTIN METHANESULFONATE SODIUM (CMS) AND MULTIPLE DOSES OF RO7033877 IN HEALTHY SUBJECTS
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Sep 2015
Price :
$35
*
At a glance
- Drugs Colistimethate sodium (Primary) ; Murepavadin (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Roche
- 25 Mar 2015 Status changed from active, no longer recruiting to completed.
- 09 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 23 Feb 2015 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.